Your browser doesn't support javascript.
loading
Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma.
Kam, Ngar Woon; Wu, Ka Chun; Dai, Wei; Wang, Ying; Yan, Leo Yik Chun; Shakya, Reshma; Khanna, Rajiv; Qin, Yanru; Law, Simon; Lo, Anthony Wing Ip; Lee, Victor Ho Fun; Guan, Xin-Yuan; Kwong, Dora Lai-Wan.
Afiliação
  • Kam NW; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 1/F, Professorial Block, 102 Pokfulam Road, Pok Fu Lam, Hong Kong.
  • Wu KC; Laboratory for Synthetic Chemistry and Chemical Biology Limited, Hong Kong Science and Technology Parks, Sha Tin, New Territories, Hong Kong.
  • Dai W; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 1/F, Professorial Block, 102 Pokfulam Road, Pok Fu Lam, Hong Kong.
  • Wang Y; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 1/F, Professorial Block, 102 Pokfulam Road, Pok Fu Lam, Hong Kong.
  • Yan LYC; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 1/F, Professorial Block, 102 Pokfulam Road, Pok Fu Lam, Hong Kong.
  • Shakya R; Department of Medicine and Therapeutics, Faculty of Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Khanna R; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4029, Australia.
  • Qin Y; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4029, Australia.
  • Law S; Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
  • Lo AWI; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Lee VHF; Department of Anatomical Pathology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Guan XY; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 1/F, Professorial Block, 102 Pokfulam Road, Pok Fu Lam, Hong Kong.
  • Kwong DL; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 1/F, Professorial Block, 102 Pokfulam Road, Pok Fu Lam, Hong Kong. xyguan@hku.hk.
Angiogenesis ; 25(2): 181-203, 2022 05.
Article em En | MEDLINE | ID: mdl-34617194
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Proteína HMGB1 / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Angiogenesis Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hong Kong
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Proteína HMGB1 / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Angiogenesis Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hong Kong